Ameresco (AMRC): GMO discloses 9.23% stake, 3,203,393 shares
Grantham, Mayo, Van Otterloo & Co. LLC (GMO) filed Amendment No. 3 to a Schedule 13G reporting its beneficial ownership of Ameresco Inc. (AMRC) common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Grantham, Mayo, Van Otterloo & Co. LLC (GMO) filed Amendment No. 3 to a Schedule 13G reporting its beneficial ownership of Ameresco Inc. (AMRC) common stock. GMO reported beneficial ownership of 3,203,393 shares, representing 9.23% of the class, as of the event date 09/30/2025.
The filing states GMO has sole voting power and sole dispositive power over 3,203,393 shares, with no shared voting or dispositive power. GMO is identified as an investment adviser (IA). The certification affirms the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Ameresco.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Ameresco (AMRC) did GMO report on its Schedule 13G/A?
What is the relevant date for GMO’s AMRC ownership in this filing?
How is GMO classified in the Ameresco (AMRC) Schedule 13G/A?
What does GMO’s certification in the 13G/A say about control intent?
Which class of Ameresco securities is covered?
AI-generated analysis. How Rhea-AI works. Not financial advice.